APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics
- PMID: 1473342
- DOI: 10.1016/0169-2607(92)90103-e
APIS: a software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics
Abstract
APIS is a software package based on mathematical modelling which provides a reliable approach in optimizing drug therapy. It was designed to assist clinicians in interpreting blood drug levels so that drug therapy may be better and more cost-effective. It is a methodological approach to describe, predict and control the kinetic behaviour of a drug. This software incorporates the principle of Bayesian procedures, i.e. one can use all available patient information (population) to determine patient-specific parameter estimates. These estimates can then be used to design an optimal and individualized drug regimen. APIS is an attractive and useful tool for clinical and experimental pharmacokinetics. APIS may be used on any IBM compatible computer using the Microsoft-Windows environment. The software is menu driven to provide a very user-friendly tool for analysing pharmacokinetic data and for designing dosage regimens.
Similar articles
-
Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.Int J Biomed Comput. 1994 Jun;36(1-2):135-7. doi: 10.1016/0020-7101(94)90105-8. Int J Biomed Comput. 1994. PMID: 7927853
-
Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.Int J Biomed Comput. 1994 Jun;36(1-2):127-30. doi: 10.1016/0020-7101(94)90103-1. Int J Biomed Comput. 1994. PMID: 7927851
-
[Validation of a new interactive software monitoring a controlled-flow infusion pump for cisplatin dosage regimen adjustment].Bull Cancer. 1996 Aug;83(8):664-76. Bull Cancer. 1996. PMID: 8869047 Review. French.
-
Progress in strategies for dosage regimen individualization.Curr Top Med Chem. 2012;12(15):1669-77. doi: 10.2174/156802612803531315. Curr Top Med Chem. 2012. PMID: 22978335
-
Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package.Anticancer Res. 1994 Nov-Dec;14(6A):2321-6. Anticancer Res. 1994. PMID: 7825966 Review.
Cited by
-
Quinine distribution in mice with Plasmodium berghei malaria.Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):11-20. doi: 10.1007/BF03190862. Eur J Drug Metab Pharmacokinet. 2003. PMID: 14503660
-
Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.Antimicrob Agents Chemother. 2004 Nov;48(11):4422-6. doi: 10.1128/AAC.48.11.4422-4426.2004. Antimicrob Agents Chemother. 2004. PMID: 15504872 Free PMC article. Clinical Trial.
-
Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.Antimicrob Agents Chemother. 1998 Apr;42(4):862-7. doi: 10.1128/AAC.42.4.862. Antimicrob Agents Chemother. 1998. PMID: 9559797 Free PMC article.
-
Pharmacokinetics and metabolism of pirarubicin in humans: correlation with pharmacodynamics.Cancer Chemother Pharmacol. 1995;36(3):239-43. doi: 10.1007/BF00685853. Cancer Chemother Pharmacol. 1995. PMID: 7781145
-
Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.Eur J Clin Pharmacol. 2003 Feb;58(10):649-52. doi: 10.1007/s00228-002-0546-2. Epub 2003 Jan 29. Eur J Clin Pharmacol. 2003. PMID: 12610739 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources